Cerebrospinal fluid levels of chitinase 3-like 1 and interleukin-6 can predict response to platform therapies in relapsing multiple sclerosis.

Saved in:
Bibliographic Details
Title: Cerebrospinal fluid levels of chitinase 3-like 1 and interleukin-6 can predict response to platform therapies in relapsing multiple sclerosis.
Authors: Mathey, Guillaume1,2 (AUTHOR) g.mathey@chru-nancy.fr, Epstein, Jonathan2,3 (AUTHOR), Alix, Tom4,5 (AUTHOR), Julien, Melissa6 (AUTHOR), Nisse, Estelle7 (AUTHOR), Pittion-Vouyovitch, Sophie1 (AUTHOR), Prunis, Chloé1 (AUTHOR), Malaplate, Catherine7,8 (AUTHOR)
Source: Journal of Neurology. Sep2025, Vol. 272 Issue 9, p1-10. 10p.
Database: Academic Search Ultimate
Description
ISSN:03405354
DOI:10.1007/s00415-025-13321-8